MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool

Overview of attention for article published in Seminars in Hematology (ScienceDirect), March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 1,017)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
twitter: 14 X users
patent: 6 patents

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 17 X posts from 14 X users, with an upper bound of 78,598 followers.

RT @DrOlaLandgren: MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool. Even More I…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.